Acura Pharmaceuticals : Termination of Material Agreement
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to... -Today at 11:24 am- MarketScreener
United States New York Petera Clemens Commission File Number Abuse Deterrent Pharma Exchange Commission
Source: marketscreener.com